Abstract
The spectrum of inflammatory pericardial syndromes includes acute, chronic and recurrent (relapsing) pericarditis, pericardial effusion and cardiac tamponade as well as constrictive pericarditis. The etiology of pericardial diseases is extensive, including infectious, non-infectious, systemic and autoimmune causes. A substantial proportion of idiopathic pericarditis represents viral infections or autoreactive pericarditis. The diagnosis of pericardial diseases is based on clinical presentation, electrocardiogram changes and echocardiographic findings. Pericardiocentesis, pericardioscopy with pericardial biopsy and contemporary pathology, immunohistochemistry and molecular biology techniques have extended the diagnostic armamentarium and contributed to etiopathogenetic understanding and treatment in pericardial diseases. Nevertheless, in uncomplicated cases, resolving to conventional anti-inflammatory treatment such a comprehensive approach is clinically not justified. On the other side, in chronic, recurrent or resistant forms an etiological diagnosis enables specific treatment. Furthermore, intrapericardial treatment after pericardiocentesis with cytostatic agents (cisplatin or thiotepa) in malignant pericardial effusions or sclerosing agents (triamcinolone, gentamycin) in chronic recurrent autoreactive effusions may prevent recurrences. Pericardiocentesis is life saving in cardiac tamponade and indicated in large effusions (> 20 mm in echocardiography in diastole), and suspected purulent, tuberculous and neoplastic pericarditis. Pericardiectomy is the only treatment for permanent constriction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Maisch B, Ristic AD (2002) The classification of pericardial disease in the age of modern medicine. Curr Cardiol Rep 4(1): 13–21
Maisch B, Ristic AD, Pankuweit S (2002) Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone: The way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 23: 1503–8
Spodick DH (1997) The Pericardium: A Comprehensive Textbook. Marcel Dekker, New York
Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmüller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH (2004) Guidelines on the diagnosis and management of pericardial diseases. Executive summary (Full text, educational slides, and pocket guidelines are available at www.escardio.org.) Eur Heart J 25(7): 587–610
Spodick DH (2001) Pericardial diseases. In: Braunwald E, Zipes DP, Libby P (eds): Heart Disease. 6th ed. Saunders, Philadelphia, 823–1866
Spodick DH (1975) Pericardial rub: Prospective, multiple observer investigation of pericardial friction in 100 patients. Am J Cardiol 35: 357–62
Bruce MA, Spodick DH (1980) Atypical electrocardiogram in acute pericarditis: Characteristics and prevalence. J Electrocardiol 13: 61–6
Imazio M, Demichelis B, Parrini I, Giuqqia M, Cecchi E, Gaschino G, Demarie D, Ghisio A, Trinchero R (2004) Day-hospital treatment of acute pericarditis: A management program for outpatient therapy. J Am Coll Cardiol 43(6): 1042–6
Lange RA, Hillis D (2004) Acute pericarditis. N Engl J Med 351: 2195–2202
Imazio M, Demichelis B, Cecchi E, Belli R, Ghisio A, Bobbio M, Trinchero R (2003) Cardiac troponin I in acute pericarditis. J Am Coll Cardiol 42(12): 2144–8
Permanyer-Miralda G (2004) Acute pericardial disease: Approach to the aetiologic diagnosis. Heart 90(3): 252–4
Maisch B, Soler-Soler J, Hatle L, Ristic A (2006) Pericardial diseases. In: Serruys PW, Camm AJ, Lüscher TF (eds): The ESC Textbook of Cardiovascular Medicine. Blackwell, London, 517–34
Adler Y, Finkelstein Y, Guindo J, Rodriguez de la Serna A, Shoenfeld Y, Bayes-Genis A, Saquie A, Bayes de Luna A, Spodick DH (1998) Colchicine treatment for recurrent pericarditis: A decade of experience. Circulation 97: 2183–5
Maisch B (2005) Recurrent pericarditis: Mysterious or not so mysterious. Eur Heart J 26: 631–633
Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G (2004) Relapsing pericarditis. Heart 90(11): 1364–8
Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, Soler-Soler J (2000) Clinical clues to the causes of large pericardial effusions. Am J Med 109(2): 95–101
Horowitz MS, Schultz CS, Stinson EB, Harrison DC, Popp RL (1974) Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation 50(2): 239–47
Talreja DR, Edwards WD, Danielson GK, Schaff HF, Tajik AI, Tazelaar HD, Breen JF, Oh JK (2003) Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation 108: 1852–7
Seferovic PM, Spodick DH, Maisch B (eds) (2000) Pericardiology. Contemporary answers to continuing challenges. Science, Belgrade
Leya FS, Arab D, Joyal D, Shioura KM, Lewis BM, Steen LH, Cho L (2005) The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Coll Cardiol 45: 1900–1902
Maisch B, Ristic AD, Seferovic PM (2000) New directions in diagnosis and treatment of pericardial disease: An update by the Taskforce on pericardial disease of the World Heart Federation. Herz 25(8): 769–80
Sagrista-Sauleda J, Barrabes JA, Permanyer-Miralda G, Soler-Soler J (1993) Purulent pericarditis: Review of a 20-year experience in a general hospital. J Am Coll Cardiol 22: 1661–5
Ustunsoy H, Celkan MA, Sivrikoz MC, Kazaz H, Kilinc M (2002) Intrapericardial fibrinolytic therapy in purulent pericarditis. Eur J Cardiothorac Surg 22(3): 373–6
Sagrista-Sauleda J, Permanyer-Miralda G, Soler-Soler J (1988) Tuberculous pericarditis: Ten year experience with a prospective protocol for diagnosis and treatment. J Am Coll Cardiol 11(4): 724–8
Strang JI, Nunn AJ, Johnson DA, Casbard A, Gibson DG, Girlinq DJ (2004) Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: Results at 10 years follow-up. QJM 97(8): 525–35
Ntsekhe M, Wiysonge C, Volmink JA, Commerford PJ, Mayosi BM (2003) Adjuvant corticosteroids for tuberculous pericarditis: Promising, but not proven. Q J Med 96: 593–9
Rostand SG, Rutsky EA (1990) Pericarditis in end-stage renal disease. Cardiol Clin 8: 701–6
Lundin AP (1990) Recurrent uremic pericarditis: A marker of inadequate dialysis. Semin Dial 3: 5–9
Maisch B, Berg PA, Kochsiek K (1979) Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. I. Relevance of antibody pattern. Clin Exp Immunol 38: 189–97
Porte HL, Janecki-Delebecq TJ, Finzi L, Metois DG, Millaire A, Wurtz AJ (1999) Pericardioscopy for primary management of pericardial effusion in cancer patients. Eur J Cardiothorac Surg 16(3): 287–91
Martinoni A, Cipolla CM, Cardinale D, Civelli M, Lamantia G, Colleoni M, Fiorentini C (2004) Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa. Chest 126(5): 1412–6
Bishiniotis TS, Antoniadou S, Katseas G, Mouratidou D, Litos AG, Balamoutsos N (2000) Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa). Am J Cardiol 86(3): 362–4
Maisch B, Ristic AD, Pankuweit S, Neubauer A, Moll R (2002) Neoplastic pericardial effusion: Efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 23: 1625–31
Tomkowski WZ, Wisniewska J, Szturmowicz M, Kuca P, Burakowski J, Kober J, Fijalkowska A (2004) Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade. Support Care Cancer 12(1): 53–7
Spodick DH (2003) Acute cardiac tamponade. N Engl J Med 349(7): 684–90
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Basel
About this chapter
Cite this chapter
Maisch, B., Karatolios, K., Pankuweit, S., Ristic, A. (2010). Pathogenesis, diagnosis and treatment of pericarditis. In: Schultheiss, HP., Noutsias, M. (eds) Inflammatory Cardiomyopathy (DCMi). Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8352-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8352-7_1
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8351-0
Online ISBN: 978-3-7643-8352-7
eBook Packages: MedicineMedicine (R0)